StockData
SOPHiA GENETICS SA logo

SOPHiA GENETICS SA (SOPH) stock

SOPHNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 3, 2026Score 4/30
$7.45+0.01 (+0.13%)

Close on Nov 17, 2026Market cap $510.22MP/E –Yield –

Earnings

SOPHiA GENETICS's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$23.31M
+27.2% on a year earlier
EPS, Q2 FY2026
-$0.30
-$0.33 a year earlier
Latest guidance
Issued
Mar 3, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of SOPHiA GENETICS's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 4, 2026before the open$23.31M+27.2%-$0.30Release
Q4 FY2025ended Dec 31, 2025Mar 3, 2026before the open$21.70M+22.6%-$0.28Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025before the open$18.32M+15.9%-$0.33Release
Q4 FY2024ended Dec 31, 2024Mar 4, 2025before the open$17.70M+4.1%-$0.23Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$15.81M+5.0%-$0.23Release
Q4 FY2023ended Dec 31, 2023Mar 5, 2024before the open$17.00M–-$0.37Release
Q2 FY2023ended Jun 30, 2023Aug 8, 2023before the open$15.05M–-$0.33Release
Q4 FY2022ended Dec 31, 2022Mar 7, 2023before the open–––Release
Q2 FY2022ended Jun 30, 2022Aug 9, 2022before the open–––Release
Q4 FY2021ended Dec 31, 2021Mar 15, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

SOPHiA GENETICS's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Full-year revenueGAAPFY2026$92.00M – $94.00M–NewMar 3, 2026
Adjusted EBITDA lossnon-GAAPFY2026$29.00M – $32.00M–NewMar 3, 2026

Guidance history

Every forecast SOPHiA GENETICS put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 3, 2026Adjusted EBITDA lossFY2026$29.00M – $32.00MNew
Mar 3, 2026Full-year revenueFY2026$92.00M – $94.00MNew
Mar 4, 2025Adjusted EBITDA lossFY2025$35.00M – $39.00MNew
Mar 4, 2025Full-year revenueFY2025$72.00M – $76.00MNew
Mar 5, 2024Adjusted gross marginFY202472.5% – 72.7%New
Mar 5, 2024Adjusted operating lossFY2024$45.00M – $50.00MNew
Mar 5, 2024RevenueFY2024$78.00M – $81.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases SOPHiA GENETICS filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?